TRACERx Renal CAPTURE Sub-study

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

NCT02724878 ·Status: COMPLETED ·Phase: PHASE2

A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer

NCT00715182 ·Status: COMPLETED ·Phase: PHASE1

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

NCT07018037 ·Status: RECRUITING

An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

NCT01351571 ·Status: COMPLETED

A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

NCT04846920 ·Status: COMPLETED ·Phase: PHASE1

A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma

NCT00265135 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

NCT00065468 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

NCT05858749 ·Status: COMPLETED

Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

NCT04957160 ·Status: COMPLETED

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

NCT01727089 ·Status: COMPLETED ·Phase: PHASE2

A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

NCT05705583 ·Status: RECRUITING

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

NCT02848768 ·Status: COMPLETED

An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

NCT00492986 ·Status: COMPLETED ·Phase: PHASE3

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

NCT05287945 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

TroVax Renal Immunotherapy Survival Trial

NCT00397345 ·Status: COMPLETED ·Phase: PHASE3

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

NCT00486538 ·Status: COMPLETED ·Phase: PHASE2

Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)

NCT00569946 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

NCT01473043 ·Status: NO_LONGER_AVAILABLE

Brivanib Metastatic Renal Cell Carcinoma

NCT01253668 ·Status: TERMINATED ·Phase: PHASE2

Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)

NCT02853344 ·Status: COMPLETED ·Phase: PHASE2

Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors

NCT02700568 ·Status: COMPLETED ·Phase: PHASE2

Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma

NCT04714697 ·Status: UNKNOWN ·Phase: PHASE2

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

NCT00520533 ·Status: TERMINATED ·Phase: PHASE1

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00112840 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

NCT00077974 ·Status: COMPLETED ·Phase: PHASE2